U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C53H63ClN8O10S
Molecular Weight 1039.633
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Surzetoclax

SMILES

CO[C@@H]1CC[C@@H](CNC2=CC=C(C=C2[N+]([O-])=O)S(=O)(=O)NC(=O)C3=CC=C(C=C3N4CCCOC5=C4C=C6C=CNC6=N5)N7CCN8CC9=C(CC(C)(C)C[C@H]9OCCCOC[C@@H]8C7)C%10=CC=C(Cl)C=C%10)OC1

InChI

InChIKey=AWGQQZVAXXLVMT-ORYVFAGJSA-N
InChI=1S/C53H63ClN8O10S/c1-53(2)27-43(34-6-8-36(54)9-7-34)44-31-60-20-19-59(30-38(60)32-69-21-5-23-70-49(44)28-53)37-10-14-42(46(25-37)61-18-4-22-71-52-48(61)24-35-16-17-55-50(35)57-52)51(63)58-73(66,67)41-13-15-45(47(26-41)62(64)65)56-29-39-11-12-40(68-3)33-72-39/h6-10,13-17,24-26,38-40,49,56H,4-5,11-12,18-23,27-33H2,1-3H3,(H,55,57)(H,58,63)/t38-,39-,40+,49+/m0/s1

HIDE SMILES / InChI

Molecular Formula C53H63ClN8O10S
Molecular Weight 1039.633
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 11:00:19 GMT 2025
Edited
by admin
on Wed Apr 02 11:00:19 GMT 2025
Record UNII
C3TU3CHH6L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Surzetoclax
INN  
Official Name English
D-erythro-Hexitol, 1,5-anhydro-6-[[4-[[[4-[(4aS,10aR)-14-(4-chlorophenyl)-1,2,4a,5,8,9,10a,11,13,15-decahydro-12,12-dimethyl-7H,12H-pyrazino[2,1-g][1,5,8]benzodioxaazacycloundecin-3(4H)-yl]-2-(3,4-dihydro-2H-pyrrolo[3?,2?:5,6]pyrido[2,3-b][1,4]oxazepin-1
Preferred Name English
surzetoclax [INN]
Common Name English
SURZETOCLAX [USAN]
Common Name English
1,5-Anhydro-6-[[4-[[[4-[(4aS,10aR)-14-(4-chlorophenyl)-1,2,4a,5,8,9,10a,11,13,15-decahydro-12,12-dimethyl-7H,12H-pyrazino[2,1-g][1,5,8]benzodioxaazacycloundecin-3(4H)-yl]-2-(3,4-dihydro-2H-pyrrolo[3?,2?:5,6]pyrido[2,3-b][1,4]oxazepin-1(7H)-yl)benzoyl]ami
Systematic Name English
4-[(4aS,10aR)-14-(4-chlorophenyl)-12,12-dimethyl-1,2,4a,5,8,9,10a,11,13,15-decahydro-7H,12Hpyrazino[ 2,1-g][1,5,8]benzodioxaazacycloundecin-3(4H)-yl]-2-(3,4-dihydro-2Hpyrrolo[ 3',2':5,6]pyrido[2,3-b][1,4]oxazepin-1(7H)-yl)-N-[4-({[(2S,5R)-5-methoxyoxan-2
Systematic Name English
Code System Code Type Description
CAS
2858632-01-4
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
SMS_ID
300000048067
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
FDA UNII
C3TU3CHH6L
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
USAN
NO-36
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
NCI_THESAURUS
C206995
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
PUBCHEM
169450714
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
INN
12915
Created by admin on Wed Apr 02 11:00:19 GMT 2025 , Edited by admin on Wed Apr 02 11:00:19 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
PRECLINICAL
Related Record Type Details
ACTIVE MOIETY